What does the Global Lung Cancer Atlas show?
The Atlas provides data from around the globe on the following key lung cancer indicators:
- Existence of a cancer plan
- Existence of a cancer registry
- Implementation of the WHO Framework Convention on Tobacco Control
An explanation of the meaning of each of these indicators can be found in the Glossary.
How do I use the Global Lung Cancer Atlas?
Each dot on the map represents a country which, when you click on it, will take you to a profile for that country. The profile includes the available data on lung cancer incidence, mortality, survival and national policy for that country. Where no data is available for a country, the indicator will be greyed out. You can also search for and select a country profile from the drop down menu at the top right hand corner called 'see data by country'.
The second drop down menu at the top right hand corner of the Atlas allows you to change the data view of the world map. You will have the option to select and view weighted data for incidence and mortality across all countries and for survival across Europe. The circles on the map will vary in size. Larger circles indicate a greater number of cases, more people dying from lung cancer, or more people surviving at five years with lung cancer. Circles will not be shown for those countries that do not have that data.
How do I compare data?
To compare country profiles, you can use the comparison tool. After you have selected a country profile, in the top right hand corner of each profile there is the option to tick 'add to compare.' You can add up to four countries to the comparison tool at a time. Once you have selected your chosen countries, please return to the homepage and click 'compare' in the top right hand corner, this will open up the four country profiles you have selected for a side-by-side comparison.
How can I use the data in the Global Lung Cancer Atlas to campaign?
The Atlas is a single statistical resource for the global lung cancer community to use in national campaigning and research. The Atlas exposes the variations both between and within countries in terms of lung cancer, making a compelling case that more can be done in many nations. It is hoped that the Atlas will encourage all nations to consider what they can do to improve the quality and consistency of lung cancer diagnosis, treatment and care.